【ChiCTR2500113086】Effectiveness of Digital CBT-I and BT-I combined ACT for Insomnia and Anxiety Symptoms in Youth: A Randomised Control Trial
ChiCTR2500113086
尚未开始
/
/
/
2025-11-24
/
/
Insomnia and anxiety
Effectiveness of Digital CBT-I and BT-I combined ACT for Insomnia and Anxiety Symptoms in Youth: A Randomised Control Trial
Effectiveness of Digital CBT-I and BT-I combined ACT for Insomnia and Anxiety Symptoms in Youth: A Randomised Control Trial
1.To compare the effect of dCBT-I, dBT-I-ACT and Health Education in improving anxiety symptoms in youth 2.To compare the effect of dCBT-I, dBT-I-ACT and Health Education in improving insomnia symptoms in youth 3.To compare the effect of dCBT-I, dBT-I-ACT and Health Education in improving depressive symptoms, cognitive flexibility, dysfunctional beliefs about sleep, pre-sleep hyperarousal, and quality of life in youth
随机平行对照
其它
Stratified randomization will be employed to balance gender and age distribution.
The data analyst will remain blinded to group allocation to prevent expectation or analysis bias.
None
/
72
/
2025-11-24
2027-11-30
/
i.Chinese youth aged 15-24 years old, ii.Presence of acute insomnia disorder as determined by validated Diagnostic Interview for Sleep Patterns and Disorders (DISP), iii.Presence of anxiety features as defined by General Anxiety Disorder-7 (GAD-7) using cut-off of 15 for detecting moderate anxiety symptoms, iv.Ability to listen, speak, and read Chinese and Cantonese, and v.Written informed consent of participation into the study is given by youth and his/her parent’s if under 18 years old; In addition, individual assent will also be obtained for subjects under age 18 years old vi.Possession of a smartphone；
请登录查看i.A clinical diagnosis of psychosis, schizophrenia, bipolar disorders, or intellectual disability, ii.Having a diagnosed sleep disorder (e.g. delayed sleep phase and narcolepsy) that may potentially contribute to the disruption of sleep quantity and quality as determined by validated Diagnostic Interview for Sleep Patterns and Disorders (DISP), iii.Having a clinically significant suicidality (presence of suicidal ideation with a plan or an attempt) as assessed by The Structured Clinical Interview (SCID), and iv.Currently receiving psychological treatment and/or pharmacological treatment for insomnia or anxiety disorder.；
请登录查看The Chinese University of Hong Kong
/
The Chinese University of Hong Kong的其他临床试验
- Feasibility, Acceptability and Effectiveness of a Tailored Multidimensional Intervention for Dementia Family Caregivers in Caregiving and Mental Health Crisis: A Pilot Randomised Controlled Trial
- One-step Rehydration Thawing Method in Frozen Embryo Transfer: A pragmatic randomized controlled clinical trial (ORT-FET-RCT)
- Feasibility and Acceptability of Cognitive Behavioural Stress Management Intervention (JoyMUM) for Pregnant Women: A Pilot Randomised Controlled Trial
- Building Resilience Against Rising Temperature - The Effect of High-Intensity Interval Exercise (HIIE) on Heat Tolerance, Thermoregulatory Adaptation, and Physical Fitness: A Comparative Randomized Controlled Trial
- Effects of Care partner Online Programme for Managing BPSD and Enhancing Wellbeing (COPE‑BPSD)
- Effects of Wearing a Sauna Suit During High-Intensity Interval Exercise
- Air purifier and respiratory outcomes in childhood asthma in compromised housing environments: a hybrid effectiveness-implementation trial
- To investigate structural variations (SVs) in autism spectrum disorder (ASD) and related endophenotypes
- Young Adult Community Health Advisor (YACHA)-led Project to Promote Anti-drug Awareness among South Asian Youths and their Family in Hong Kong
- Effects of High-Intensity Interval Training on Physical Fitness, Cognitive and Mental Health in Hong Kong Adolescents with Intellectual Disabilities: A Cluster-Randomized Controlled Trial
- The Effects of Low‐ and High‐Glycemic Index Sport Nutrition Bars on Metabolism and High‐Intensity Interval Training Responses
- An innovative approach to combine intermittent dieting (INTD) with high-intensity interval exercise (HIIE) for curbing central obesity: A comparative randomized controlled trial
- Effectiveness of acceptance-based diabetes self-management (ACT-DSM) for adults with type 2 diabetes for improving diabetes distress and glycaemic control: A randomised controlled trial
- Effects of GABA with Butyrate, GABA/Butyrate-producing Synbiotics on Pain Relief in Fibromyalgia: A Phase II, Multi-Center, Double-Blinded, Randomized-Controlled Trial
- The effects of art therapy-based intervention on anxiety children with haematological cancers: a randomised controlled trial
- Effectiveness of Digital CBT-I and BT-I combined ACT for Insomnia and Anxiety Symptoms in Youth: A Randomised Control Trial
- An evidence-based advance care planning programme to promote end-of-life care planning among patients with advanced diseases in the Emergency Department – a feasibility randomised controlled trial
- WhatsApp-assisted prehabilitation programme for adult patient undergoing elective colorectal cancer surgery
- Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Hepatobiliary and Pancreatic surgery
- A pilot study on the efficacy and safety of the use of a synbiotic formula (SCV09) in people with Mild Cognitive Impairment (MCI)
Department of Psychiatry, The Chinese University of Hong Kong的其他临床试验
- Effectiveness of Digital CBT-I and BT-I combined ACT for Insomnia and Anxiety Symptoms in Youth: A Randomised Control Trial
- 定位連環透顱磁力剌激對認知障礙症患者抑鬱徵狀的療效研究
- 運動訓練與工作記憶訓練對減慢輕度阿氏痴呆症長者認知能力下降之隨機對比研究
- 個人化身心運動治療對抑鬱症及焦慮症之隨機對照臨床試驗效果研究
- A randomized controlled trial of leisure activity intervention on preservation of cognitive and everyday function in Chinese older adults with early cognitive decline
最新临床资讯
-
诺华：CFB抑制剂终止狼疮肾炎二期临床
医药笔记2026-10-17
-
泽安生物医药：实体瘤MCE启动一期临床
医药笔记2026-10-17
-
药明康德2026-10-17
-
沃森生物2026-10-16
-
罕见病信息网2026-10-16
-
武警特色医学中心2026-10-16
-
生物经纬2026-10-16
-
良医汇肿瘤资讯2026-10-16
-
BioMed科技2026-10-16
-
蒲公英资讯2026-10-16
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-10-26
-
2026-10-25
-
2026-10-25
-
摩熵咨询 33 51
-
摩熵咨询 20 3
-
摩熵咨询 20 10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
-
颁布机构：国家药品监督管理局药品审评中心 2026-09-28
-
颁布机构：国家药品监督管理局 2026-09-10
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-10-23
-
2026-10-23
-
2026-10-21
-
摩熵咨询 35 83
-
摩熵咨询 28 71
-
摩熵咨询 34 47
-
颁布机构：国家药品监督管理局 2026-10-19
-
颁布机构：国家市场监督管理总局 2026-10-16
-
颁布机构：国家市场监督管理总局 2026-09-30